Related Experiment Video
Updated: May 6, 2026

Molecular Profiling of the Invasive Tumor Microenvironment in a 3-Dimensional Model of Colorectal Cancer Cells and Ex vivo Fibroblasts
Published on: April 29, 2014
Integrating Transcriptomics and Machine Learning to Uncover the FLI1-PARP14-Immune Axis in Ulcerative Colitis
Zhizhong Zheng1, Yayu Zhang1, Zhixing Gao1
1Cancer Research Center, School of Medicine, Xiamen University, Xiamen 361102, China.
This study identified a FLI1-PARP14-immune axis crucial for ulcerative colitis (UC) activity. PARP14 shows promise as a diagnostic biomarker and therapeutic target for this chronic inflammatory bowel disease.
Area of Science:
- Gastroenterology
- Immunology
- Bioinformatics
Background:
- Ulcerative colitis (UC) is a chronic inflammatory bowel disease with incompletely understood molecular mechanisms.
- Current understanding of UC pathophysiology requires further elucidation of molecular drivers and diagnostic markers.
Purpose of the Study:
- To identify diagnostic biomarkers for UC activity.
- To unravel the pathogenic causes of UC through integrated multi-omics and machine learning approaches.
- To investigate the role of gene expression and immune cell infiltration in UC.
Main Methods:
- Utilized weighted gene co-expression network analysis (WGCNA) and differential gene expression (DEG) analysis on public gene expression datasets.
- Applied protein-protein interaction networks and ensemble machine learning to identify key genes.
- Conducted summary-data-based Mendelian Randomization (SMR) and immune infiltration analyses.
Main Results:
- Identified eight characteristic genes, with CXCL11, PARP14, and IFITM1 as significant hub genes demonstrating high diagnostic accuracy (AUC > 0.83).
- SMR analysis suggested a causal link between elevated PARP14 expression and UC susceptibility.
- Hub genes correlated strongly with immune cells like M1 macrophages and NK cells, with FLI1 identified as a key upstream regulator.
Conclusions:
- Established a FLI1-PARP14-immune axis central to UC pathogenesis.
- Highlighted PARP14 as a potential diagnostic biomarker and therapeutic target for ulcerative colitis.
- Provided novel insights into the molecular mechanisms underlying UC activity.
More Related Videos
07:05Fluorescence-mediated Tomography for the Detection and Quantification of Macrophage-related Murine Intestinal Inflammation
Published on: December 15, 2017
09:08Investigating Target Gene Function in a CD40 Agonistic Antibody-induced Colitis Model using CRISPR/Cas9-based Technologies
Published on: June 2, 2021